[1]
K. C. Yee and J. Knobloch, “Cardiovascular safety of new inhaled medications for asthma and chronic obstructive pulmonary disease: a critical review from pharmacist perspective”, Int J Res Med Sci, vol. 4, no. 6, pp. 1814–1829, Jan. 2017.